Cordycepin (3′-deoxyadenosine) inhibits the growth of B16-BL6 mouse melanoma cells through the stimulation of adenosine A3 receptor followed by glycogen synthase kinase-3β activation and cyclin D1 suppression
Cordycepin (3′-deoxyadenosine) inhibits the growth of B16-BL6 mouse melanoma cells through the stimulation of adenosine A3 receptor followed by glycogen synthase kinase-3β activation and cyclin D1 suppression
复制标题
DOI:
10.1007/s00210-007-0218-y
复制
发表时间:
2008-06-01
影响因子:
3.6
通讯作者:
Nakamura, Kazuki
中科院分区:
文献类型:
--
作者:
Yoshikawa, Noriko;Yamada, Shizuo;Nakamura, Kazuki
Cordyceps sinensis, a parasitic fungus on the larvae of Lepidoptera, has been used as a traditional Chinese medicine. We previously reported that the growth of B16-BL6 mouse melanoma (B16-BL6) cells was inhibited by cordycepin (3'-deoxyadenosine), an active ingredient of C. sinensis, and its effect was antagonized by MRS1191, a selective adenosine A(3) receptor antagonist. In this study, the radioligand binding assay using [I-125]-AB-MECA (a selective adenosine A(3) receptor agonist) has shown that B16-BL6 cells express adenosine A(3) receptors and that cordycepin binds to these receptors. We also confirmed the involvement of adenosine A(3) receptors in the action of cordycepin using MRS1523 and MRS1220, specific adenosine A(3) receptor antagonists. Next, indirubin, a glycogen synthase kinase-3 beta (GSK-3 beta) inhibitor, antagonized the growth suppression induced by cordycepin. Furthermore, the level of cyclin D-1 protein in B16-BL6 cells was decreased by cordycepin using Western blot analysis. In conclusion, this study demonstrated that cordycepin inhibits the proliferation of B16-BL6 cells by stimulating adenosine A(3) receptors followed by the Wnt signaling pathway, including GSK-3 beta activation and cyclin D-1 inhibition.